The first Elevation Oncology trade was made in Q4 2021.
Since then Jim Simons bought shares four more times and sold shares on five occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Elevation Oncology anymore.
Avg closing price
Price range
Sold -441 Thousand shares
Q1 2024
Avg closing price
$3.24
Price range
$0.59
-
$5.13
New holding (+441 Thousand shares)
Q4 2023
Avg closing price
$0.53
Price range
$0.38
-
$0.69
Sold -16.8 Thousand shares
Q3 2023
Avg closing price
$1.01
Price range
$0.65
-
$1.56
Sold 67.4% shares (-34.7 Thousand shares)
Q2 2023
Avg closing price
$2.64
Price range
$1.40
-
$5.06
Sold 74.2% shares (-148 Thousand shares)
Q1 2023
Avg closing price
$1.29
Price range
$0.75
-
$2.55
Sold 30.7% shares (-88.8 Thousand shares)
Q4 2022
Avg closing price
$1.01
Price range
$0.89
-
$1.19
Increased shares by 11.7% (+30.3 Thousand shares)
Q3 2022
Avg closing price
$1.26
Price range
$1.03
-
$1.53
Increased shares by 917.3% (+233 Thousand shares)
Q2 2022
Avg closing price
$2.51
Price range
$1.26
-
$3.94
Increased shares by 53.0% (+8.8 Thousand shares)
Q1 2022